Discrimination of Multiple [3H]5‐Hydroxytryptamine Binding Sites by the Neuroleptic Spiperone in Rat Brain

Journal of Neurochemistry - Tập 36 Số 1 - Trang 220-226 - 1981
Norman W. Pedigo1, Henry I. Yamamura1, D. L. Nelson2
1Department of Pharmacology, University of Arizona Health Sciences Center, Tucson, Arizona
2Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona.

Tóm tắt

Abstract:Certain neuroleptic drugs, such as spiperone and (+) butaclamol, can discriminate between two populations of [3H]5‐hydroxytryptamine ([3H]5‐HT) binding sites in rat brain. The butyrophenone neuroleptic spiperone shows the greatest selectivity for these two binding sites, having at least a 3000‐fold difference between its dissociation constants (2‐12 nM versus 35,000 nM) for the high‐ and low‐affinity sites, respectively. Inhibition of [3H]5‐HT binding by spiperone in rat frontal cortex and corpus striatum yields distinctly biphasic inhibition curves with Hill slopes significantly less than unity. Results from nonlinear regression analysis of these inhibition studies were consistent with a two‐site model in each brain region. In the frontal cortex the high‐affinity neuroleptic sites comprised about 60% of the total [3/H]5‐HT binding sites whereas in the corpus striatum they accounted for only 20% of the sites. Furthermore, saturation studies of [3H]5‐HT binding assayed in the absence or presence of 1 μM‐spiperone (a concentration that completely blocks the high‐affinity site while having minimal activity at the low‐affinity site) reveal a parallel shift in the Scatchard plot with no change in the dissociation constant of [3H]5‐HT, but a significant decrease (64% in frontal cortex or 28% in corpus striatum) in the number of specific binding sites. These observations are consistent with the existence of at least two populations of [3H]5‐HT binding sites having a differential regional distribution in rat brain.

Từ khóa


Tài liệu tham khảo

Aghajanian G. K., 1978, Psychopharmacology: A Generation of Progress, 171

10.1016/0006-8993(78)90385-2

Bennett J. P., 1976, Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors, Mol. Pharmacol., 12, 373

10.1016/0024-3205(77)90066-2

Birdsall N. J. M., 1978, The binding of agonists to brain muscarinic receptors, Mol. Pharmacol., 14, 723

10.1038/236385a0

Bockaert J., 1980, Serotonin—Current Aspects of Neurochemistry arid Function

Burt D. R., 1976, Binding interactions of lysergic acid diethylamide and related agents with dopamine receptors in the brain, Mol. Pharmacol., 12, 631

Chang K. J., 1979, Multiple opiate receptors: Different regional distribution in the brain and differential binding of opiates and opioid peptides, Mol. Pharmacol., 16, 91

Chang R. S. L., 1979, Characteristics of histamine H1‐receptors in peripheral tissues labeled with (3H)mepyramine, J. Pharmacol. Exp. Ther., 209, 437

10.1016/0014-2999(78)90080-8

10.1016/0024-3205(80)90300-8

Fillion G. M. B., 1978, High‐affinity binding of (3H)5‐hydroxytryptamine to brain synaptosomal membranes: Comparison with (3H)lysergic acid diethylamide binding, Mol. Pharmacol., 14, 50

10.1111/j.1471-4159.1979.tb05189.x

10.1111/j.1476-5381.1957.tb00142.x

10.1113/jphysiol.1974.sp010761

10.1007/BF02205223

Hamon M., 1980, Advances in Biochemical Psychopharmacology, Vol. 21: Receptors for Neurotransmitters and Peptide Hormones, 223

Hancock A. A., 1979, Quantitative resolution of beta‐adrenergic receptor subtypes by selective ligand binding: Application of a computerized model fitting technique, Mol. Pharmacol., 16, 1

10.1038/277093a0

Levy B., 1970, Selective interactions with beta adrenergic receptors, Fed. Proc., 29, 1362

10.1038/272168a0

10.1038/267495a0

Lovell R. A., 1976, Stereospecific receptor sites for d‐lysergic acid diethylamide in rat brain: Effects of neurotransmitters, amine antagonists, and other psycho‐tropic drugs, Mol Pharmacol., 12, 620

10.1016/S0021-9258(19)52451-6

10.1073/pnas.76.3.1135

Martin W. R., 1976, The effects of morphine‐ and nalorphine‐like drugs in the non‐dependent and morphine‐dependent chronic spinal dog, J. Pharmacol. Exp. Ther., 197, 517

10.1016/0006-8993(79)90370-6

Metzler C. M., 1974, A Users Manual for NONLIN

Minneman K. P., 1979, Simultaneous determination of β‐1‐adrenergic and β‐2‐adrenergic receptors in tissues containing both receptor subtypes, Mol. Pharmacol., 16, 34

Nelson D. L., 1978, Characteristics of central 5‐HT receptors and their adaptive changes following intracerebral 5,7‐dihydroxytryptamine administration in the rat, Mol. Pharmacol., 14, 983

Olsen R. W., 1979, GABA—Neurotransmitters: Pharmacochemical, Biochemical and Pharmacological Aspects, 165

10.1016/0014-2999(78)90154-1

Peroutka S. J., 1979, Multiple serotonin receptors: Differential binding of (3H)5‐hydroxytryptamine, (3H)lysergic acid diethylamide and (3H)spiroperidol, Mol. Pharmacol., 16, 687

10.1111/j.1471-4159.1980.tb06607.x

10.1016/0014-2999(79)90342-X

10.1016/0024-3205(79)90283-2

Thông tin
Thông tin xuất bản

Journal of Neurochemistry

Tập 36 Số 1

220-226

Thông tin tác giả